![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1421-9875|34|5|580-588
ISSN: 0257-2753
Source: Digestive Diseases, Vol.34, Iss.5, 2016-06, pp. : 580-588
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Use of Farnesoid X Receptor Agonists to Treat Nonalcoholic Fatty Liver Disease
Digestive Diseases, Vol. 33, Iss. 3, 2015-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Komichi Daisuke Tazuma Susumu Nishioka Tomoji Hyogo Hideyuki Chayama Kazuaki
Digestive Diseases and Sciences, Vol. 50, Iss. 3, 2005-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease
Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Wu Lili Li Wen Wang Zikai Yuan Zuohui Hyder Qurratulain
Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 4, 2013-04 ,pp. :